| “Periprocedural management of abnormal coagulation parameters and thrombocytopenia in patients with cirrhosis: Guidance from the SSC of the ISTH”: Comment from Hartmann et al. J Hartmann, JD Dias, G Garcia‐Tsao, EG Pivalizza Journal of Thrombosis and Haemostasis 20 (11), 2711-2712, 2022 | 1 | 2022 |
| 155P BNT113+ pembrolizumab as first-line treatment in patients with unresectable recurrent/metastatic HNSCC: Preliminary safety data from AHEAD-MERIT K Klinghammer, NF Saba, E Castelluci, AD Colevas, T Rutkowski, R Greil, ... Immuno-Oncology and Technology 16, 2022 | 4 | 2022 |
| 218 Novel thromboelastography point-of-care test detects all commercially available DOACs at therapeutic concentrations and classifies them as direct thrombin or factor Xa … JD Dias, C Lopez-Espina, J Ippolito, H Hsiao, F Zaman, B Mathew, ... European Heart Journal 39 (suppl_1), ehy564. 218, 2018 | 1 | 2018 |
| 261. Adenovirus Infection of Epithelial Cancer Cells I Diaconu, L Denby, S Pesonen, V Cerullo, GJ Bauerschmitz, K Guse, ... Molecular Therapy 17, 1, 2009 | | 2009 |
| 615. Oncolytic Adenoviruses in a Multi-Modal Combinatory Approach of HNSCC Clinical Tumor Explants JD Dias, K Guse, P Nokisalmi, M Eriksson, DT Chen, I Diaconu, ... Molecular Therapy 17, 1, 2009 | | 2009 |
| Ad5/3-delta24-aCTLA4, a targeted oncolytic adenovirus producing a human full-length monoclonal antibody for cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) J Dias, O Hemminki, T Ranki, A Bonetti, K Guse, I Diaconu, S Escutenaire, ... HUMAN GENE THERAPY 22 (10), A71-A71, 2011 | | 2011 |
| Adenoviral E4orf3 and E4orf6 Proteins, but Not E1B55K Sensitize Cancer Cells to Radiotherapy In Vivo I Liikanen, JD Dias, P Nokisalmi, M Sloniecka, L Kangasniemi, M Rajecki, ... MOLECULAR THERAPY 17, S383-S384, 2009 | | 2009 |
| Adenoviral E4orf3 and E4orf6 proteins, but not E1B55K, increase killing of cancer cells by radiotherapy in vivo I Liikanen, JD Dias, P Nokisalmi, M Sloniecka, L Kangasniemi, M Rajecki, ... International Journal of Radiation Oncology* Biology* Physics 78 (4), 1201-1209, 2010 | 6 | 2010 |
| Adenoviral Gene Therapy for Advanced Head and Neck Cancer JD Afonso de Carvalho Dias Helsingin yliopisto, 2010 | | 2010 |
| CANCER-TARGETED GENE & CELL THERAPY I JD Dias, I Liikanen, K Guse, J Foloppe, M Sloniecka, I Diaconu, ... Molecular Therapy 18, 1, 2010 | | 2010 |
| Cartridge-based thromboelastography can be used to monitor and quantify the activity of unfractionated and low-molecular-weight heparins JD Dias, CG Lopez-Espina, M Panigada, HJ Dalton, J Hartmann, ... TH Open 3 (03), e295-e305, 2019 | 17 | 2019 |
| Clinical pearls: Laboratory assessments of direct oral anticoagulants (DOACS) RC Gosselin, J Douxfils, D Adcock Phlebologie 47 (04), 215-221, 2018 | | 2018 |
| Comparison of three common whole blood platelet function tests for in vitro P2Y12 induced platelet inhibition JD Dias, T Pottgiesser, J Hartmann, D Duerschmied, C Bode, HE Achneck Journal of thrombosis and thrombolysis 50, 135-143, 2020 | 23 | 2020 |
| Diagnosis and treatment of trauma-induced coagulopathy by viscoelastography J Hartmann, M Walsh, A Grisoli, AV Thomas, F Shariff, R McCauley, ... Seminars in Thrombosis and Hemostasis 46 (02), 134-146, 2020 | 45 | 2020 |
| Effects of edoxaban on the cellular and protein phase of coagulation in patients with coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel: results … F Franchi, F Rollini, E Garcia, JR Rios, A Rivas, M Agarwal, M Kureti, ... Thrombosis and Haemostasis 120 (01), 083-093, 2020 | 26 | 2020 |
| Emerging Use of Viscoelastography in Thrombosis and Hemostasis: A Challenge to Conventional Coagulation Tests?—Part II: Thromboelastography-Guided Therapy Enhances Patient … J Hartmann, JD Dias, EG Pivalizza, G Garcia-Tsao Seminars in Thrombosis and Hemostasis 49 (2), 162, 2023 | | 2023 |
| ESGCT, DGGT, GSZ, and ISCT 2009 Poster Presentations A Bisgin, A Kargi, A Yalcin, C Aydin, B Savas, S Sanlioglu, H Karlsson, ... Human Gene Therapy 20 (11), 1417-1545, 2009 | | 2009 |
| Global coagulation assays to measure in vitro fibrinolysis JD Dias, E Shafizadeh, J Leiriao, J Hartmann Thrombosis Update 4, 100052, 2021 | 3 | 2021 |
| Induction of interferon pathways mediates in vivo resistance to oncolytic adenovirus I Liikanen, V Monsurrò, L Ahtiainen, M Raki, T Hakkarainen, I Diaconu, ... Molecular Therapy 19 (10), 1858-1866, 2011 | 63 | 2011 |
| Key technologies for improving Patient Blood Management J Dias, M Popovsky | 1 | |
Jan HartmannHaemonetics Corporation, Boston, MA, U.S.A.在 haemonetics.com 的电子邮件经过验证
